WHO ICTRP trial

Effects of Modafinil and Caffeine during the circadian trough on vigilance in…

EUCTR2017-002288-16-NL · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2017-002288-16-NL
Public title Effects of Modafinil and Caffeine during the circadian trough on vigilance in healthy RNLAF aircrew: a randomized controlled trial
Scientific title Effects of Modafinil and Caffeine during the circadian trough on vigilance in healthy RNLAF aircrew: a randomized controlled trial
Primary sponsor Center for Man in Aviation
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes
Countries Netherlands
Conditions fatigue in healthy aircew;Therapeutic area: Not possible to specify
Interventions Trade Name: Aspendos Modiodal Modafinil (generic) Pharmaceutical Form: Capsule Pharmaceutical form of the placebo: Capsule Route of administration of the placebo: Oral use Product Name: Coffeine Product Code: As yet unknown Pharmaceutical…
Registration date Mar 10, 2017
Target size 36
Secondary IDs MOCAFFE
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations